Experimental CAR t therapy targets Hard-to-Treat AL amyloidosis
NCT ID NCT07250269
First seen Dec 08, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This early-phase trial tests a new treatment called GC012F for people with AL amyloidosis that has come back or not responded to prior therapy. The therapy uses specially engineered immune cells to target two proteins on harmful cells. The study will enroll 9 adults to check safety and whether the treatment can reduce disease signs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY AL AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBeijing, 100034, China
-
Research Site
RECRUITINGBeijing, 100070, China
-
Research Site
RECRUITINGBeijing, CN-100730, China
-
Research Site
RECRUITINGChangchun, 130021, China
-
Research Site
RECRUITINGGuangzhou, 510100, China
-
Research Site
NOT_YET_RECRUITINGHangzhou, 310003, China
-
Research Site
RECRUITINGSuzhou, 215006, China
-
Research Site
RECRUITINGWenzhou, 325000, China
-
Research Site
NOT_YET_RECRUITINGWuhan, 430022, China
Conditions
Explore the condition pages connected to this study.